A tweet and a chart to think about.
Was traveling in midwest y'day to see ISI clients. Huge generalist interest in biotech & pharma right now. I mean off the charts.Mark Schoenebaum (@MarkSchoenebaum) February 20, 2014
The $5.2 billion takeout of Ariad Pharma was the biggest news from the closely followed healthcare conference.
A selloff in crude oil proves another roadblock in the Dow Jones Industrial Average's pursuit of 20,000.
Here's what the market chose to focus on instead.